Magic mushroom drug tested to ease surgery pain and cut opioid use
NCT ID NCT07406828
Summary
This early-stage study is testing whether a single dose of psilocybin, the active compound in 'magic mushrooms,' is safe and practical to give to adults recovering from major trauma surgery who also have opioid use disorder. Researchers want to see if this one-time dose can help reduce post-surgery pain, lower anxiety and depression, and decrease the need for opioid painkillers during recovery. The study will involve 70 participants who are in the hospital after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
UPMC Presbyterian
Pittsburgh, Pennsylvania, 15213, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.